A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance

Trial Profile

A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Avibactam/ceftaroline fosamil (Primary)
  • Indications Bacterial infections; Systemic inflammatory response syndrome
  • Focus Pharmacokinetics
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 13 Nov 2012 Planned End Date changed from 1 Jul 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 26 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top